Hemerus Medical, LLC
Hemerus Medical, LLC specializes in designing and developing innovative blood collection, processing, preservation, and storage technologies. Their mission is to improve patient transfusion outcomes and ensure the availability of high-quality, life-saving blood products. Hemerus aims to extend the shelf life of blood products and enhance transfusion safety through advanced technologies like leukocyte reduction filters and novel anticoagulant solutions.
Hemerus Medical, LLC
5000 Township Parkway, Saint Paul, MN 55110-5852, USA
What We Do
The SOLX™ System is FDA approved for pre-storage leukocyte reduction of CPD whole blood and preparation of AS-7 Red Cells, Leukocytes Reduced. It also includes preparation of Fresh Frozen Plasma and Plasma Frozen Within 24 Hours After Phlebotomy. The system is expected to be available for sale in October 2025.
LEUP™ processing circuit technology enables leukoreduction of blood products in a one-step, vent-free process, improving efficiency and freeing up operators' time.
LEUKOSEP™ filters are designed to effectively remove leukocytes from blood products, providing high efficiency leukoreduction with low residual hold up.
Biologics
News & Updates
Hemerus Medical received patents for developing DEHP-free blood collection and storage systems, addressing health and environmental concerns.